Metastatic Renal Cell Carcinoma
3 competing products in clinical development for Metastatic Renal Cell Carcinoma.
Pipeline by Phase
Phase 1/21
Phase 22
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| AGS-16C3F + Axitinib | Astellas Pharma | Phase 2 | Completed | 35 |
| Lenvatinib + Everolimus | Eisai | Phase 1/2 | Completed | 32 |
| Tivozanib + Sunitinib | Astellas Pharma | Phase 2 | Terminated | 27 |